Top Companies in Upstream Bioprocessing Market
The global upstream bioprocessing market was evaluated at US$ 24.15 billion in 2023 and is expected to attain around US$ 105.46 billion by 2034, growing at a CAGR of 14.34% from 2024 to 2034.
The top key players in upstream bioprocessing are Thermo Fisher Scientific, Inc., Merck KGaA, Corning Incorporated, Sartorius AG, Eppendorf AG, Danaher, Boehringer Ingelheim GmbH, Applikon Biotechnology, PBS Biotech, Inc., Lonza, VWR International, LLC, Meissner Filtration Products, Inc., Repligen Corporation, Entegris and Kuhner AG.
Latest Announcements by Market Leaders
- In November 2024, Thermo Fisher is expanding its operations in India through a bioprocess design center. Biotech giant Thermo Fisher Scientific is building a bioprocess manufacturing facility in Hyderabad, Telangana, India.
- In 2024, Boehringer Ingelheim will refine its animal health bioprocess technology business and make a bigger impact on environmental sustainability to reduce its footprint.
Recent Developments
- In August 2024, MilliporeSigma, the life sciences business of Merck KGaA in the U.S. and Canada, Darmstadt, Germany, announced that the company’s life sciences division has completed the acquisition of Mirus Bio for approximately $600 million (approximately €550 million), following regulatory approvals and fulfillment of other closing conditions.
- In September 2023, Repligen Corporation, a life sciences company focused on leadership in bioprocess technologies, announced that it has entered into a definitive agreement to acquire Metenova AB (Metenova), a privately held company headquartered in Mölndal, Sweden. There is a growing need for commercial-grade magnetic stirring systems for use in upstream and downstream applications. Expands Repligen’s liquid management portfolio to complement single-use bag offering.
If you have any questions, please feel free to contact us at
